Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA

Journal of Lipid Research

Volumn 49, Issue 12, 2008, Pages 2648-2656

  Leduc, Magalie S ^a   Shimmin, Lawrence C ^a   Klos, Kathy L E ^a   Hanis, Craig ^a   Boerwinkle, Eric ^a   Hixson, James E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apolipoprotein E levels; Dietary cholesterol transport; Functional polymorphisms; HDL cholesterol; Hepatic cholesterol transport; LDL cholesterol; Nonsynonymous substitutions; Protein folding; Reverse cholesterol transport; SNP haplotypes; Triglyceride levels

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; BETA2 GLYCOPROTEIN 1; CIS ACTING ELEMENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AMINO ACID SUBSTITUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; DIABETES MELLITUS; EUROPEAN AMERICAN; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HISPANIC; HUMAN; HYPERTENSION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; CAUCASIAN; GENETICS; GENOTYPE; METABOLISM; MULTICENTER STUDY; NEGRO;

AFRICAN CONTINENTAL ANCESTRY GROUP; BETA 2-GLYCOPROTEIN I; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; LIPID METABOLISM; MULTICENTER STUDIES AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 59649126068     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800155-JLR200     Document Type: Article

References (31)

1. Polz, E., and G. M. Kostner. 1979. The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett. 102: 183-186.
2. Polz, E., G. M. Kostner, and A. Holasek. 1979. Studies on the protein composition of human serum very low density lipoproteins: demonstration of the beta 2-glycoprotein-I. Hoppe Seylers Z. Physiol. Chem. 360: 1061-1067.
3. Nakaya, Y., E. J. Schaefer, and H. B. Brewer, Jr. 1980. Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem. Biophys. Res. Commun. 95: 1168-1172.
4. Schousboe, I. 1980. Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity. Thromb. Res. 19: 225-237.
5. Schousboe, I. 1985. Beta 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood. 66: 1086-1091.
6. Nimpf, J., E. M. Bevers, P. H. Bomans, U. Till, H. Wurm, G. M. Kostner, and R. F. Zwaal. 1986. Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim. Biophys. Acta. 884: 142-149.
7. McNeil, H. P., R. J. Simpson, C. N. Chesterman, and S. A. Krilis. 1990. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA. 87: 4120-4124.
8. Jones, J. V., H. James, M. H. Tan, and M. Mansour. 1992. Antiphospholipid antibodies require beta 2-glycoprotein I (apolipoprotein H) as cofactor. J. Rheumatol. 19: 1397-1402.
9. Sanghera, D. K., D. R. Wagenknecht, J. A. McIntyre, and M. I. Kamboh. 1997. Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding. Hum. Mol. Genet. 6: 311-316.
10. Mehdi, H., M. Nunn, D. M. Steel, A. S. Whitehead, M. Perez, L. Walker, and M. E. Peeples. 1991. Nucleotide sequence and expression of the human gene encoding apolipoprotein H (beta 2glycoprotein I). Gene. 108: 293-298.
11. Kamboh, M. I., R. E. Ferrell, and B. Sepehrnia. 1988. Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I). Am. J. Hum. Genet. 42: 452-457.
12. Sanghera, D. K., T. Kristensen, R. F. Hamman, and M. I. Kamboh. 1997. Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism. Hum. Genet. 100: 57-62.
13. Chen, Q., and M. I. Kamboh. 2006. Complete DNA sequence variation in the apolipoprotein H (beta-glycoprotein I) gene and identification of informative SNPs. Ann. Hum. Genet. 70: 1-11.
14. Sepehrnia, B., M. I. Kamboh, L. L. Adams-Campbell, C. H. Bunker, M. Nwankwo, P. P. Majumder, and R. E. Ferrell. 1989. Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations. Hum. Genet. 82: 118-122.
15. Kaprio, J., R. E. Ferrell, B. A. Kottke, M. I. Kamboh, and C. F. Sing. 1991. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler. Thromb. 11: 1330-1348.
16. Cassader, M., G. Ruiu, R. Gambino, F. Guzzon, A. Pagano, F. Veglia, R. Pagni, and G. Pagano. 1994. Influence of apolipoprotein H polymorphism on levels of triglycerides. Atherosclerosis. 110: 45-51.
17. Takada, D., Y. Ezura, S. Ono, Y. Iino, Y. Katayama, Y. Xin, L. L. Wu, S. Larringa-Shum, S. H. Stephenson, S. C. Hunt, et al. 2003. Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family. J. Atheroscler. Thromb. 10: 79-84.
18. Daniels, P. R., S. L. Kardia, C. L. Hanis, C. A. Brown, R. Hutchinson, E. Boerwinkle, and S. T. Turner. 2004. Genetic Epidemiology Network of Arteriopathy Study. The familial aggregation of hypertension treatment and control in the GENOA study. Am. J. Med. 116: 676-681.
19. Carlson, C. S., M. A. Eberle, M. J. Rieder, Q. Yi, L. Kruglyak, and D. A. Nickerson. 2004. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74: 106-120.
20. Almasy, L., and J. Blangero. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62: 1198-1211.
21. Blangero, J., J. T. Williams, and L. Almasy. 2000. Quantitative trait locus mapping using human pedigrees. Hum. Biol. 72: 35-62.
22. Laird, N. M., S. Horvath, and X. Xu. 2000. Implementing a unified approach to family-based tests of association. Genet. Epidemiol. 19 (Suppl.): 36-42.
23. Benjamini, Y., D. Drai, G. Elmer, N. Kafkafi, and I. Golani. 2001. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125: 279-284.
24. Mehdi, H., S. Manzi, P. Desai, Q. Chen, C. Nestlerode, F. Bontempo, S. C. Strom, R. Zarnegar, and M. I. Kamboh. 2003. A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur. J. Biochem. 270: 230-238.
25. Mehdi, H., C. E. Aston, D. K. Sanghera, R. F. Hamman, and M. I. Kamboh. 1999. Genetic variation in the apolipoprotein H (beta2glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum. Genet. 105: 63-71.
26. Kamboh, M. I., S. Manzi, H. Mehdi, S. Fitzgerald, D. K. Sanghera, L. H. Kuller, and C. E. Atson. 1999. Genetic variation in apolipoprotein H (beta2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus. Lupus. 8: 742-750.
27. Mehdi, H., A. Naqvi, and M. I. Kamboh. 2000. A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding. Eur. J. Biochem. 267: 1770-1776.
28. Schwarzenbacher, R., K. Zeth, K. Diederichs, A. Gries, G. M. Kostner, P. Laggner, and R. Prassl. 1999. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 18: 6228-6239.
29. Klos, K. L., S. L. Kardia, J. E. Hixson, S. T. Turner, C. Hanis, E. Boerwinkle, and C. F. Sing. 2005. Linkage analysis of plasma apoE in three racial groups: multiple genes with context-dependent effects. Ann. Hum. Genet. 69: 157-167.
30. Bosse, Y., M. F. Feitosa, J-P. Despres, B. Lamarche, T. Rice, D. C. Rao, C. Bouchard, L. Perusse, and M-C. Vohl. 2005. Detection of a major gene effect for LDL peak particle diameter and association with apolipoprotein H gene haplotype. Atherosclerosis. 182: 231-239.
31. Polz, E., H. Wurm, and G. M. Kostner. 1980. Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions. Int. J. Biochem. 11: 265-270.